Regulation of human renin gene promoter activity: A new negative regulatory region determines the responsiveness to TNFα  Ling-Sing K. Chen, Michael P.

Slides:



Advertisements
Similar presentations
Volume 56, Issue 5, Pages (November 1999)
Advertisements

Volume 48, Issue 6, Pages (June 2011)
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Fig. 7 Localization of the element(s) responsible for the transcriptional suppression by PPAR-γ. A, Rat VSMCs were transfected with either −1969/+104-luc,
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome  Henry K. Wong, Heather Gibson,
Volume 11, Issue 6, Pages (June 2003)
Volume 55, Issue 1, Pages (July 2014)
Regulation of expression of murine transferrin receptor 2
Julie M. Caldwell, PhD, Carine Blanchard, PhD, Margaret H
Volume 133, Issue 6, Pages (December 2007)
The homeodomain protein Cdx2 regulates lactase gene promoter activity during enterocyte differentiation  Rixun Fang, Nilda A. Santiago, Lynne C. Olds,
Volume 55, Issue 2, Pages (February 1999)
Masanori Ono, M. D. , Ph. D. , Ping Yin, Ph. D. , Antonia Navarro, M
Human mesangial cells express inducible macrophage scavenger receptor
PPAR-γ agonist protects podocytes from injury
Volume 16, Issue 4, Pages (October 2009)
IFN-γ Upregulates Expression of the Mouse Complement C1rA Gene in Keratinocytes via IFN-Regulatory Factor-1  Sung June Byun, Ik-Soo Jeon, Hyangkyu Lee,
Expression and regulation of MD-2s.
Volume 16, Issue 6, Pages (December 2004)
The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells  Jane Eddleston, PhD, Jack Herschbach,
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
Volume 56, Issue 5, Pages (November 1999)
Transcriptional activation of transforming growth factor-β1 in mesangial cell culture by high glucose concentration  Brenda B. Hoffman, Kumar Sharma,
Volume 53, Issue 3, Pages (September 2010)
Pseudomonas Aeruginosa- and IL-1β-Mediated Induction of Human β-Defensin-2 in Keratinocytes Is Controlled by NF-κB and AP-1  Kai Wehkamp, Lars Schwichtenberg,
Volume 138, Issue 5, Pages e2 (May 2010)
J. F Schaefer, M. S. , M. L Millham, M. A. , B de Crombrugghe, M. D
Volume 64, Issue 5, Pages (November 2003)
Volume 62, Issue 3, Pages (September 2002)
An Autocrine Loop Mediates Expression of Vascular Endothelial Growth Factor in Human Dermal Microvascular Endothelial Cells  Barbara Vega-Diaz, Serge.
Toshiaki Monkawa, Tadashi Yoshida, Matsuhiko Hayashi, Takao Saruta 
Volume 5, Issue 4, Pages (April 2000)
Impaired Proteasome Function Activates GATA3 in T Cells and Upregulates CTLA-4: Relevance for Sézary Syndrome  Heather M. Gibson, Anjali Mishra, Derek.
Cell-Density-Dependent Regulation of Expression and Glycosylation of Dopachrome Tautomerase/Tyrosinase-Related Protein-2  Thomas J. Hornyak, Daniel J.
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Volume 60, Issue 3, Pages (September 2001)
Transcriptional Regulation of ATP2C1 Gene by Sp1 and YY1 and Reduced Function of its Promoter in Hailey–Hailey Disease Keratinocytes  Hiroshi Kawada,
Histamine Inhibits the Production of Interferon-induced Protein of 10 kDa in Human Squamous Cell Carcinoma and Melanoma  Naoko Kanda, Shinichi Watanabe 
Volume 55, Issue 6, Pages (June 1999)
C-Jun Downregulation by HDAC3-Dependent Transcriptional Repression Promotes Osmotic Stress-Induced Cell Apoptosis  Yan Xia, Ji Wang, Ta-Jen Liu, W.K.
Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor  Dai Iwakiri, Daniel K. Podolsky 
Volume 58, Issue 4, Pages (October 2000)
Stephen E. Gould, Maria Day, Simon S. Jones, Haimanti Dorai 
P. Harding, L. Balasubramanian, J. Swegan, A. Stevens, W.F. Glass 
17β-estradiol Inhibits the Production of RANTES in Human Keratinocytes
Spatial and Temporal Recruitment of Androgen Receptor and Its Coactivators Involves Chromosomal Looping and Polymerase Tracking  Qianben Wang, Jason S.
Regulation of the Melanoma Cell Adhesion Molecule Gene in Melanoma: Modulation of mRNA Synthesis by Cyclic Adenosine Monophosphate, Phorbol Ester, and.
Volume 65, Issue 1, Pages (January 2004)
Differential Gene Induction of Human β-Defensins (hBD-1, -2, -3, and -4) in Keratinocytes Is Inhibited by Retinoic Acid  Jürgen Harder, Ulf Meyer-Hoffert,
Volume 134, Issue 1, Pages (January 2008)
Volume 127, Issue 4, Pages (October 2004)
PPARδ Is a Type 1 IFN Target Gene and Inhibits Apoptosis in T Cells
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
BMP-4 Upregulates Kit Expression in Mouse Melanoblasts prior to the Kit-Dependent Cycle of Melanogenesis  Tamihiro Kawakami, Satoko Kimura, Yoko Kawa,
Volume 39, Issue 5, Pages (November 2003)
Volume 26, Issue 3, Pages (May 2007)
Volume 61, Issue 5, Pages (May 2002)
Volume 67, Issue 6, Pages (June 2005)
Amanda O'Donnell, Shen-Hsi Yang, Andrew D. Sharrocks  Molecular Cell 
Volume 57, Issue 2, Pages (October 2000)
Volume 70, Issue 5, Pages (September 2006)
Volume 54, Issue 6, Pages (January 1998)
Volume 55, Issue 2, Pages (February 1999)
John M. Lamar, Vandana Iyer, C. Michael DiPersio 
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Volume 55, Issue 1, Pages (July 2014)
A Splicing-Independent Function of SF2/ASF in MicroRNA Processing
Fang Wang, Yunfeng Wang, Jie Ding, Jiyun Yang  Kidney International 
Transcriptional Regulation of the Elafin Gene in Human Keratinocytes
Presentation transcript:

Regulation of human renin gene promoter activity: A new negative regulatory region determines the responsiveness to TNFα  Ling-Sing K. Chen, Michael P. Cuddy, Lucille A. LaVallette  Kidney International  Volume 54, Issue 6, Pages 2045-2055 (January 1998) DOI: 10.1046/j.1523-1755.1998.00209.x Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 Plasmid construction and expression of the hREN-luciferase reporter genes in transiently transfected cells. (A) The construction strategy and the maps of the hREN promoter-luciferase fusion genes. Restriction sites are shown as: S, SacI; P, PstI; N, NcoI; B, BamHI. AUG represents the translation initiation codon of the reporter luciferase gene. (B) Relative luciferase activities expressed in the cell lines transiently transfected with pSVOAL, 2.7Luci, 4.0Luci, and 5.0Luci, respectively. In these transient transfection experiments, cells (25,000 cells per well) were cotransfected with a pSV-βgal plasmid and luciferase activities were normalized to β-galactosidase activities to adjust for differences in transfection efficiency. Symbols are: (▪) Y-1; () Neuro-2A; (▪) JEG-3; () CHO-K1; () COS7. Luciferase activities in the transected CHO-K1 and COS cells were negligible (close to the baseline). Results are given as mean ± sem of the percentage of luciferase activity detected in the 2.7Luci-transfected Y-1 cell lysate. Each bar represents three to five independent transfections in triplicate wells. Kidney International 1998 54, 2045-2055DOI: (10.1046/j.1523-1755.1998.00209.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 2 Effects of forskolin, calcium ionophore, phorbol ester, and angiotensin II on luciferase expression in stably-transfected 5.0S61 cells. The 5.0S61 cells were plated at 50,000 cells per well, then incubated for six hours with the following compounds at concentrations indicated, and cell lysates were prepared for luciferase assays. Compounds used were forskolin (FK), calcium ionophore (A23187), phorbol myristate acetate (PMA), and angiotensin II (Ang II), respectively. Results are given as mean ± sem of the percentage of luciferase activity in the untreated 5.0S61 cell lysates. Each bar represents three independent transfections in triplicate wells. Symbols are: (▪) untreated; () 0.1 μm; (▪) 0.10 μm; () 1.00 μm; (□) 10.0 μm. Kidney International 1998 54, 2045-2055DOI: (10.1046/j.1523-1755.1998.00209.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 3 Effect of Ang II treatment on luciferase expression in 5.0S61 cells transiently transfected with human AT1 receptor cDNA. The 5.0S61 cells were plated at 25,000 cells per well, then transfected with either pSVL vector plasmid (Pharmacia) or pSVL containing human AT1 receptor cDNA, using the lipofectin reagent for six hours. After incubation in the complete media for two days, cells were treated for 14-hours without Ang II (0.1% DMSO instead), with Ang II alone, or with Ang II and losartan, at concentrations indicated. Subsequently, cell lysates were analyzed in the luciferase assays. Results are given as mean ± sem of the percentage of luciferase activity in the untreated 5.0S61 cell lysates. Each bar represents two independent experiments in triplicate wells. Kidney International 1998 54, 2045-2055DOI: (10.1046/j.1523-1755.1998.00209.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 4 Effects of cytokines on luciferase expression in 5.0S61 cells. The 5.0S61 cells were plated at 50,000 cells per well and incubated for 24hours with the cytokine, as shown, at the concentrations of 0, 2, 10, 20, and 100ng/ml, respectively, and cell lysates were analyzed in the luciferase assays. Results are given as mean values of the percentage of luciferase activity in the untreated 5.0S61 cell lysates. Each line represents three independent experiments in triplicate wells. Symbols are: (□) TNFα; (⋄) IL-1α; (○) IL-1β; (▵) IL-2; (⊞) IL-6. Kidney International 1998 54, 2045-2055DOI: (10.1046/j.1523-1755.1998.00209.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 5 Effect of TNFα treatment on renin mRNA expression in Y-1 cells. Two hundred and fifty nanograms of total RNA isolated from Y-1 cells treated with 0, 10, 20, or 100ng/ml TNFα, respectively, for 24hours, were reverse transcribed and amplified for 35 cycles for analysis of renin mRNA expression. Primers for GAPDH were added in the same RT-PCR tube as an internal control. The TNFα-induced reduction in renin mRNA levels were normalized with the GAPDH mRNA levels. Results are given as the percentage of renin mRNA levels detected in the untreated Y-1 cells. Each point represents mean ± sem obtained from two independent RT-PCR experiments. Kidney International 1998 54, 2045-2055DOI: (10.1046/j.1523-1755.1998.00209.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 6 mRNA expression of cytokines and cytokine receptors in Y-1 cells. Five hundred nanograms of total RNA isolated from cultured Y-1 cells were reverse transcribed and amplified, using target specific primers, for 35 cycles for analyzing mRNA expression of cytokines (IL-1β, and TNFα), and cytokine receptors (IL-1 receptor, TNF receptor I, and TNF receptor II). Lanes shown are: (1) positive control templates for each respective gene (provided by Clontech Laboratories); (2) Y-1 total RNA; (3) Y-1 total RNA without reverse transcription. Size marker (M) contains fragments of (from top to bottom) 1000, 700, 525, 500, 400, 300, 200, 100, and 50bp. The RT-PCR products representing the respective mRNA are marked with asterisks (*). Kidney International 1998 54, 2045-2055DOI: (10.1046/j.1523-1755.1998.00209.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 7 Effects of forskolin and TNFα on luciferase expression in Y-1 cells transiently-transfected with the 5.0Luci or 3.5Del plasmid. Y-1 cells (25,000 cells per well) were transiently transfected with pSVOAL (promoterless plasmid), 5.0Luci, or 3.5Del plasmid (A), as well as the pSV-βgal plasmid for normalizing differences in transfection efficiency (Methods section). At 36hours after transfection, cells were treated for 24hours with vehicle 0.1% DMSO, 5 μm forskolin, or TNFα at concentrations indicated, and luciferase activities in the cell lysates were assayed. Results (B) are given as mean ± sem of the percentage of luciferase activity detected in the 5.0Luci-transfected cells from two independent transfections in triplicate wells. Kidney International 1998 54, 2045-2055DOI: (10.1046/j.1523-1755.1998.00209.x) Copyright © 1998 International Society of Nephrology Terms and Conditions